Lymphocyte apoptosis and apoptosis-associated gene expression in sjogren's syndrome

Arthritis and Rheumatism

Volumn 39, Issue 11, 1996, Pages 1875-1885

  Ogawa, Noriyoshi ^a   Dang, Howard ^b   Kong, Liping ^b   Anaya, Juan Manuel ^b   Liu, George Tye ^c   Talal, Norman ^c  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Corp para Invest Biologicas ^*  (Colombia)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SJOEGREN SYNDROME; SOUTHERN BLOTTING; T LYMPHOCYTE;

ADULT; AGED; APOPTOSIS; B-LYMPHOCYTES; BLOTTING, SOUTHERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 0029970916     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391114     Document Type: Article

References (42)

1. Ogawa N, Dang H, Talal N: Apoptosis and autoimmunity. J Autoimmun 8:1-19, 1995
2. Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992
3. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100-103, 1994
4. + T cell-mediated cytotoxicity. J Immunol 152:1127-1133, 1994
5. Takahashi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S: Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol 6:1567-1574, 1994
6. Bell DA, Morrison B, VandenBygaart P: Immunogenic DNA-related factors: nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest 85:1487-1496, 1990
7. Mohan C, Adams S, Stanik V, Datta SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177:1367-1381, 1993
8. Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach J-F, Jacob L: Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr mice and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum 37:1684-1688, 1994
9. Akbar AN, Borthwick N, Salmon M, Gombert W, Bofill M, Shamsadeen N, Pilling D, Pett S, Grundy JE, Janossy G: The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections: the role of apoptosis in T cell memory. J Exp Med 178:427-438, 1993
10. Akbar AN, Savill J, Gombert W, Bofill M, Borthwick NJ, Whitelaw F, Grundy J, Janossy G, Salmon M: The specific recognition by macrophages of CD8+, CD45RO+ T cells undergoing apoptosis: a mechanism for T cell clearance during resolution of viral infections. J Exp Med 180:1943-1947, 1994
11. Osborne BA, Schwartz LM: Essential genes that regulate apoptosis. Trends Cell Biol 4:394-398, 1994
12. Korsmeyer SJ: Regulators of cell death. Trends Genet 11:101-105, 1995
13. Hoffman B, Liebermann DA: Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene 9:1807-1812, 1994
14. Strasser A, Senga W, Vaux DL, Bath ML, Adams CS, Harris AW: Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8661-8665, 1991
15. Andrews BS, Frisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ: Sponaneous murine lupus-like syndromes: clinical and immunopathological manifestations in several strains. J Exp Med 148:1198-1215, 1978
16. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci U S A 90:10340-10344, 1993
17. Ramsdell F, Seaman MS, Miller RE, Tough TW, Alderson MR, Lynch DH: Gld/gld mice are unable to express a functional ligand for Fas. Eur J Immunol 24:928-933, 1994
18. Allen RD, Marshall JD, Roths JB, Sidman CL: Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules. J Exp Med 172:1367-1375, 1990
19. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946, 1995
20. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fisher A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349, 1995
21. Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152:3685-3692, 1994
22. Mysler E, Bini P, Drappa J, Ramos P, Friedman S, Krammer PH, Elkon KB: The apoptosis-1/fas protein in human systemic lupus erythematosus. J Clin Invest 93:1029-1034, 1994
23. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection of fas-mediated apoptosis by a soluble form of the fas molecule. Science 263:1759-1762, 1994
24. Talal N, Moutsopoulos HM, Kassan SS, editors: Sjögren's Syndrome: Clinical and Immunological Aspects. Berlin, Springer-Verlag, 1987
25. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiødt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P: Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347, 1993
26. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
27. Alard P, Lantz O, Sebagh M, Calvo CF, Weill D, Chavanel G, Senik A, Charpentier B: A versatile ELISA-PCR assay for mRNA quantitation from a few cells. Biol Techniques 15:730-737, 1993
28. Rashtchian A: Amplification of RNA. PCR Methods and Applications 4:S83-S91, 1994
29. Koretzky GA, Daniele RP, Nowell PC: A phorbol ester (TPA) can replace macrophages in human lymphocyte cultures stimulated with a mitogen but not with an antigen. J Immunol 128:1776-1780, 1982
30. Van Houten N, Budd RC: Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J Immunol 149:2513-2517, 1992
31. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR: Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214, 1992
32. Bissonnette RP, McGahon A, Mahboubi A, Green DR: Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J Exp Med 180:2413-2418, 1994
33. Boumpas DT, Tsokos GC, Mann DL, Eleftheriades EG, Harris CC, Mark GE: Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases. Arthritis Rheum 29:755-760, 1986
34. Klinman DM, Mushinski JF, Honda M, Ishigatsubo Y, Mountz JD, Raveche ES, Steinberg AD: Oncogene expression in autoimmune and normal peripheral blood mononudear cells. J Exp Med 163:1292-1307, 1986
35. Boumpas D, Eleftheriades EG, Molina R, Barez S, Atkinson J, Older SA, Balow JE, Tsokos GC: C-myc proto-oncogene expression in peripheral blood mononuclear cells from patients with primary Sjögren's syndrome. Arthritis Rheum 33:49-56, 1990
36. Gatenby PA, Irvine M: The bcl-2 proto-oncogene is overexpressed in systemic lupus erythematosus. J Autoimmun 7:623-631, 1994
37. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB: High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 37:1423-1430, 1994
38. Ohsako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S: Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 73:109-114, 1994
39. Reed JC, Miyashita T, Cuddy M, Cho D: Regulation of p26-Bcl-2 protein levels in human peripheral blood lymphocytes. Lab Invest 67:443-449, 1992
40. Reed JC, Tsujimoto Y, Alpers JD, Croce CM, Nowell PC: Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 236:1295-1299, 1987
41. Granniger W, Seto M, Boutain B, Goldman P, Korsmeyer S: Expression of bcl-2 and bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 80:1512-1515, 1987
42. Malone DG, Wahl SM, Tsokos M, Cattell H, Decker JL, Wilder RL: Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest 74:1173-1185, 1984